Navigation Links
Researchers work to boost effectiveness of the flu vaccine
Date:6/8/2009

AUGUSTA, Ga. Vaccines intended to help the body to fight off the flu bug may actually give the bug an edge, researchers say.

That doesn't mean vaccines are bad, it just may help explain why they aren't as good as they could be, says Dr. Andrew Mellor, director of the Immunotherapy Center at the Medical College of Georgia and Georgia Research Alliance Eminent Scholar in Molecular Immunogenetics.

His team along with viral immunology experts at the University of Georgia believe they can improve the efficacy of flu vaccines maybe even make them work for more than one flu season by taking away the bug's advantage.

It's a scenario Dr. Mellor equates to a brake and a gas pedal: when an infection or a vaccine feigning an infection gets the attention of the immune system, the body also mounts a counter-regulatory response to make sure the fighting doesn't get out of hand.

The enzyme, indoleamine 2,3 dioxygenase, or IDO, is part of that response. MCG researchers, led by Drs. Mellor and David Munn, showed in 1998 that fetuses use IDO to avoid rejection by the mother's immune system. IDO's silencing effect is hijacked by tumors and chronic infectious agents like HIV to avoid getting eliminated by the immune response. Acute infections such as the flu, which surface with a vengeance but typically are cleared by the body in a matter of days, appear to subscribe as well.

"We don't even understand the primary response to the influenza infection let alone to a live, attenuated virus used in vaccines," says Dr. Ralph Tripp, viral immunologist, director of UGA's Center for Disease Intervention and Georgia Research Alliance Chair of Animal Health Vaccine Development. "I think if we can understand how IDO regulates the response to viral infections, we can likely build better vaccines."

To better understand both, the researchers are using a flu-infected mouse to identify the lung cells expressing IDO, the signals prompting the expression and the effect on T cells, the orchestrators of the immune response. They also are using different methods to block IDO in the mouse model then see what happens to the infection, the T-cell driven immune response and the immune system's memory of it all.

"We are trying to put together models of who tells who what to do and in what sequence. IDO is somewhere in this chain of events," says Dr. Mellor, the principal investigator on a five-year, $3.1 million grant from the National Institute of Allergy and Infectious Diseases to help dissect IDO's role. "I guess the simplest hope we have is that by manipulating IDO, in this case by blocking it, we can get T cell vaccines to work much better."

A study published in the Proceedings of the National Academy of Sciences in March supports the theory. An international team of researchers, led by the University of Melbourne, Australia, showed that a vaccine adjuvant given to help boost the efficiency of the influenza vaccine instead boosted IDO expression, hurting the vaccine's ability to provide flu protection.

"This suggests that vaccinologists may have been underestimating the potential efficacy of vaccines because vaccines themselves or adjuvants delivered with vaccines induced IDO that attenuated the host immune response and blunted development of protective immunity," Dr. Mellor says.

An IDO inhibitor, already in clinical trials for tumors, may be the adjuvant that really gives vaccine a kick, the researchers say.

They believe a sticking point for vaccines generally is that most are designed to activate T cells. While it seems like a logical approach, the fact is most T-cell vaccines don't work that well. Among their many roles, T cells are killer cells that recognize and hopefully eliminate infected cells, which can become infection factories. In fact, scientists believe T cell vaccines should prompt recognition and elimination of different strains of influenza, rather than the Centers for Disease Control and Prevention perennially trying to predict strains for the next flu season and drug makers continuously making new vaccines.

Most viral infections are seasonal and show up looking a little different each year, which is why vaccines vary yearly, notes Dr. Tripp, a professor in the UGA College of Veterinary Medicine. Most influenza infections are mild, accompanied by classic symptoms such as fever and malaise. In fact the general misery associated with the flu is actually the body's response to fighting it. People often mistakenly think the attenuated, or weakened, virus used in the flu vaccine makes them sick when it's actually evidence the body is mounting an immune response, Dr. Mellor says.

Less than 20 percent of influenza infections are severe and a fraction about 36,000 annually in the United States - go on to cause death. Secondary infections, such as pneumonia, typically contribute to mortality, Dr. Tripp says.


'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers work to boost effectiveness of the flu vaccine
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a hot ... suggests that Americans prefer their dogs straight off the grill. Of the 90 percent ... favorite way to cook a hot dog, far outpacing other cooking methods such as ...
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... ... MadgeTech will be showcasing its line of data logging products , ... MadgeTech headquarters. With products sold in more than 100 countries around the world, MadgeTech ... , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech data loggers around ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the ... Insurance is sharing tips to make sure your family and vehicle are ready ... Safety Council, there may be 439 deaths and an additional 50,500 serious injuries from ...
(Date:5/26/2016)... Rafael, CA (PRWEB) , ... May 26, 2016 ... ... will be offering campers a multitude of activities from daily practices, arts & ... self-confidence. , Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... India , May 27, 2016 ... the instances of hypertension is driving ambulatory blood pressure ... lose their elasticity and their ability to respond to ... pressure. This condition can lead to various cardiovascular disorders ... peripheral vascular disease. These diseases are growing in prevalence ...
(Date:5/26/2016)... New York , May 26, 2016 ... Market Research "Medical Waste Management Market - U.S. Industry Analysis, ... medical waste management market in the U.S. was valued at ... at a CAGR of 3.4% from 2015 to 2023 to ... provides exhaustive analysis of current and emerging needle free drug ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
Breaking Medicine Technology: